Found 1,713 results
By Jon D. Markman On December 22, 202207:00 AM Eastern
Medical researchers are using what they know about our immune system and computers to make startling advances.
By Kenny Polcari On August 30, 202212:00 PM Eastern
This week, I speak with Gavin Magor, director of ratings & research at Weiss for over 14 years, about a new service, All-Weather Portfolio, which is designed to use the ratings to protect investors.
By Jessica Borg On August 9, 202207:00 AM Eastern
Financial News Anchor Jessica Borg interviews Research Analyst Sam Blumenfeld about recession-resilient stocks across a diverse range of sectors, and why dividend raisers are crucial in this climate.
By The Weiss Ratings Team On May 31, 202210:39 AM Eastern
Financial News Anchor Jessica Borg interviews Research Analyst Sam Blumenfeld about 1 sector that’s outperforming the broad market as sell-offs, corrections and volatility continue.
Folks, the internet giveth, and the internet taketh away.
For Twitter, it’s that times a million.
Let’s start with the June 2020 issue of Weiss Ratings Crypto Investor, where we talked about a...
By Jon D. Markman On August 1, 201804:59 PM Eastern
Big Pharma is in a rut. The industry keeps spending more and yet making fewer scientific breakthroughs.
But help is on the way.
Last week, GlaxoSmithKline (GSK) announced a radical change in...
By The Weiss Ratings Team On February 9, 201807:55 AM Eastern
Dear Investor,
On Thursday, I shared important news about some exciting enhancements to your Weiss Ratings Briefing -- including the details of our new and improved line up of market experts....
By The Weiss Ratings Team On February 8, 201807:55 AM Eastern
Dear Investor,
I’m pleased to announce some exciting enhancements – and welcome some new market experts – to your Weiss Ratings Briefing line up. Beginning this coming Monday, February 12, you...
By Mandeep Rai On April 19, 201707:00 AM Eastern
Yes, reports on retail sales, jobs, inflation and manufacturing in the very recent past have missed expectations. That’s why the Atlanta Fed Model depicts a paltry 0.5% growth rate. But I sure...
By Jon D. Markman On February 21, 201707:30 AM Eastern
You probably haven’t heard about precision medicine. That’s fine, it wasn’t even possible ten years ago.
But now we’re entering the new Gilded Age — and suddenly researchers are using it to...